University Of Ottawa;University Of Maryland, Baltimore;University of Rochester
发明人:
KEILLOR, Jeffrey W.,AKBAR, Abdullah,ECKERT, Richard L.,FISHER, Matthew,JOHNSON, Gail V.W.
申请号:
EP17782038
公开号:
EP3442533A4
申请日:
2017.04.13
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
There are provided Tissue Transglutaminase (TG2) inhibitor compounds, and compositions and methods of use thereof for the prevention or treatment of a cancer. Compounds of Formula I, and pharmaceutically acceptable salts thereof, are provided: Formula (I).